Tuberculosis is the most common multi-systemic infection, with various types of manifestation and clinical description, lung is the most common location for developing tuberculosis disease (WHO, 2018). As many as 58% of cases of pulmonary TB occur in 3 (three) countries such as Southeast Asia. Based on profile Service Health Maluku Province, in 2021 number of invention Pulmonary TB cases Service Health (Health Office) of Maluku Province to end in 2019 it reached 6,379 people or by 0.35 percent of total population in the province the largest as 1.8 million people.This research uses a quantitative observational design with a cross sectional approach. With sample use systematic type Purposive sampling of 83 respondents. Data analysis using linear regression. Results test statistics show the most influential variable to level pulmonary tuberculosis treatment is a level indicator compliance with level significance sig 0.000. Based on the results of the Multiple Linear Regression analysis, it shows that with a p-value of 0.00 0 < 0.05, H 1 is accepted, so it is concluded that there is a simultaneous influence quality of life as well as the level of compliance of TB lung sufferers And body mass index on post treatment tb lung at DR M Haulussy Ambon Regional Hospital.

ZENODO DOI:- https://doi.org/10.5281/zenodo.14038194

Quality Life, Compliance Level, Body Mass Index

Ambarwati F.R., 2014. Konsep Kebutuhan Dasar Manusia. Parama Ilmu.Yogyakarta. 20-23.

Anggarwal A., 2010. Health-related Quality of Life : A Negected aspect of Pulmonary Tuberculosis. Lung lindia. Vol 27. UCB India.

Anita, Y., & Candrawati, E., & W, R. C. A. (2018). Hubungan pengetahuan pasien tuberculosis tentang penyakit tuberculosis dengan kepatuhan berobat di unit rawat jalan Rumah Sakit Panti Waluya Sawahan Malang. Nursing News, 3(3), 729-735.

Bali, D. K. (2018). Profil kesehatan provinsi bali 2018. In Dinas Kesehatan Provinsi Bali. https://www.diskesbaliprov.go.id

Budianto, A. (2015). Usia dan pendidikan berhubungan dengan perilaku kepatuhan minum obat pada penderita TB paru. Jurnal Ilmiah Kesehatan, 4(8). https://doi.org/10.35952/jik.v4i8.19

Chang B., Wu A., Hansel N., Diette G. 2004. Quality of Life : A Review of English Lenguage Literature. Quality of Life Research. edisi 13. Kluwer Academic Publisher. Netherlands. 1633-1642.

Depkes RI. 2004. Pengembangan Kebijakan DEPKES dalam Penanggulangan TB Anak. Depkes RI. Jakarta. 1-8.

Depkes RI. 2006. Pedoman Nasional Penanggulangan Tuberkulosis. Edisi 2.Gardunas-TB Depkes RI. Jakarta.

Dewi, N. L. K. F., Puspawati, N. L. P. D., & Sumberartawan, I. M. (2019). Gambaran kepatuhan minum obat pada penderita tuberkulosis paru. Journal Center of Research Publication in Midwifery and Nursing, 3(1), 45–51. https://doi.org/10.36474/caring.v3i1.118.

Dinas Kesehatan Kabupaten Buleleng. (2018). Profil kesehatan kabupaten buleleng tahun 2018. Buleleng : Dinas Kesehatan Kabupaten Buleleng.

Dye C., Scheele S., Dolin P., Pathania V., Raviglione M.C. 1999. Global burden of tuberculosis: estimated incidence, prevalence and mortality by country. JAMA. 282:677-86.

Guo N., Marra F., Marra C.A. 2009. Measuring health-related quality of life in tuberculosis: a systematic review. Health qulity of life outcomes. Biomed center.

Hadi, S. 2001. Chi Kwadrad. Metodologi research. cetakan Ketujuhbelas. Andi Offset. Yogyakarta. 343-357.

Guyatt G.H., and Jaeschke R. Measurement in Clinical Trials : Choosing the Appropriate Approach. In : Spilker (editor) Quality of Life Assessment in Clinical Trials. Raven Press, Ltd. New York, 1990

Kementerian Kesehatan RI. 2012. Profil Kesehatan Jawa Barat. www.depkes.go.id.

Kementerian Kesehatan RI. 2013. Ringkasan Eksekutif Data dan Informasi Kesehatan Provinsi Jawa Barat. www.depkes.go.id.

Lemeshow, S., Hosmer Jr, D.W., Klar, J., Lwanga, S.K. 1990. Adequacy of Sample Size in Health Studies. Terjemahan Pramono, D., 1997. Besar Sampel Dalam Penelitian Kesehatan. Gadjah Mada University Press. Yogyakarta. 12-20.

Marra A.C., Marra F., Cox V., Palepu A., Fitzgerald J. 2004. Factors influencing quality of life in patients with active tuberculosis. Health and Quality Life Outcome. Biomed central. 1-10.

Murti, B. 2003. Prinsip dan Metode Reset Epidemiologi. Edisi 2. Gajah Mada University Press. Jogyakarta.

Perhimpunan Dokter Paru Indonesia (PDPI). 2006. Tuberkulosis Pedoman Diagnosis dan Penatalaksanaan di Indonesia.

Rahmawan A. 2004. Kualitas Hidup Penderita Karsinoma Nasofaring Pascaterapi. Perbandingan antara yang mendapat radioterapi dengan kombinasi radioterapi ditambah kemoterapi. Tesis. UGM

Ratnasari N. 2004. Hubungan Dukungan Sosial dengan Kualitas Hidup pada Penderita Tuberkulosis Paru di Balai Pengobatan Penyakit Paru-paru (BP4) Yogyakarta Unit Minggiran. Skripsi. UGM.

Reichman L.B. 1996. How to ensure the continued resurgence of tuberculosis.Lancet. 347:175-7.

Santoso J., Mahendradhata Y., Utarini A. 2008. Cost-effectivenes Jejaring BP4 dengan Puskesmas dalam Penanganan Tuberkulosis. Jurnal Respirasi Indonesia. Vol. 28. 32-38.

Testa M.A., and Simonson D.C. 1996. Assessment of Quality of Life Outcomes.N Engl J Med : 334 : 834-840.

Unalan D., Soyuer F., Ceyhan O., Basturk M., Ozturk A. 2006. Is the Quality of Life Different in Patients with active and inactive Tuberculosis? Indian Journal of Tuberculosis 2008. 55: 127-137.

Ware J.E. 2005. Instrumen Review : SF-36 Health Survey (Version 1.0). Autralian Health Outcomes Collaburation (AHOC). CHSD University of Wallongong. Autralia

WHO. 2009. Global tuberkulosis control. World Health Organization. Geneva. WHO. 2009. Treatment of Tuberculosis Guidelines. Edisi 4. World Health Organization. Geneva.

WHO. 2010. The Global Burden of TB. Stop TB Department, World Health Organization. Geneva.